Article Sidebar

pdf
Date Published: 25/09/2023
Abstract Views: 94
Views pdf: 85
DOI: https://doi.org/10.51298/vmj.v530i1B.6737
Issue
Vol. 530 No. 1B (2023)
Section
Các bài báo
How to Cite
Nguyễn, T. N., Nguyễn, T. P. T., Trần, H. P., Nguyễn, T. Q. L., & Lê, X. H. (2023). RESULTS OF TREATMENT FOR ELDERLY PATIENTS STAGE IV LUNG ADENOCARCINOMA WITH PEMETREXED-CARBOPLATIN. Vietnam Medical Journal, 530(1B). https://doi.org/10.51298/vmj.v530i1B.6737

RESULTS OF TREATMENT FOR ELDERLY PATIENTS STAGE IV LUNG ADENOCARCINOMA WITH PEMETREXED-CARBOPLATIN

Thanh Ngọc Nguyễn1,, Thị Phương Thảo Nguyễn1, Hoàng Phương Trần1, Thị Quỳnh Lan Nguyễn1, Xuân Hà Lê2
1 108 Military Central Hospital
2 Huu Nghi Hospital, Hanoi

Main Article Content

Abstract

Evaluation of tumor response and relationship between disease control rate and some factors in elderly patients with stage IV lung adenocarcinoma treated with Pemetrexed-Carboplatin regimen. Subjects and methods: retrospectively and prospectively, 37 patients were treated at the Military Central Hospital from January 2020 to March 2023. Results: mean age 67 ± 4.1 (60-74); male/female ratio = 2.7/1. Objective response rate was 35.1%; disease control rate was 59.5%. Conclusion: Pemetrexed-Carboplatin regimen for the treatment of elderly patients with stage IV lung adenocarcinoma gave a similar response rate to other regimens, similar to other age groups.

Article Details

Keywords

non-small cell lung cancer, adenocarcinoma, pemetrexed, carboplatin, elderly.

References

Hyuna Sung et al (2021). Global Cancer Statistics 2020: GLOBOCAN Estimate of Incidence and Mortality Worldwide for 36 Cancer in 185 Countries. CA Cancer J Clin 2021; 71(3):209-249.
2. Scagliotti G.V., Parikh P., von Pawel J. et al (2008). Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol Off J Am Soc Clin Oncol, 26(21), 3543–3551.
3. Grønberg B.H., Bremnes R.M., Fløtten Ø. et al (2009). Phase III Study by the Norwegian Lung Cancer Study Group: Pemetrexed Plus Carboplatin Compared With Gemcitabine Plus Carboplatin As First-Line Chemotherapy in Advanced Non–Small-Cell Lung Cancer. JCO, 27(19), 3217–3224.
4. Ito M. et al (2019). Carboplatin plus pemetrexed for the elderly incurable chemo-naive nonsquamous non-small cell lung cancer: Meta-analysis. Asia Pac J Clin Oncol, 15(2), e3-e10.
5. Eisenhauer E.A., Therasse P., Bogaerts J. et al (2009). New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer, 45(2), 228–247.
6. Phạm Văn Thái (2015). Đánh giá kết quả điều trị ung thư phổi không tế bào nhỏ di căn não bằng hoá chất phác đồ PC kết hợp xạ phẫu dao gamma quay, Luận án Tiến sĩ Y học, Trường Đại học Y Hà Nội.
7. Lê Văn Khảm (2014). Vấn đề người cao tuổi hiện nay. Tạp trí khoa học xã hội Việt Nam, 7, 80.